CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Psyllium +2 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05911347
NCT05911347N/ACompleted

Effect of Modified Cellulose on Colonic Fermentation of Inulin (COCOA2)

University of Nottingham·interventional·Posted Jun 22, 2023·Updated Aug 15, 2024

In Brief

A clinical study evaluating Psyllium, Methylcellulose, and 1 other intervention for Irritable Bowel Syndrome. Completed, enrolled 30 participants across 1 site.

Detailed Summary

A 3-way randomised cross-over study to test the hypothesis that combining either psyllium or methylcellulose to form a gel incorporating inulin will reduce gas production as compared to inulin given with a placebo, maltodextrin. Subjects will attend on 3 separate days separated by a minimum of one week an consume one of 3 test meals. Serial breath samples with be obtained to measure hydrogen and methane over the next 24 hours. Primary endpoint: Area under curve (AUC) from time 0-6 hours (AUC 0-6) of breath hydrogen (ppm.hour) after treatment intake. The investigators will also assess whole gut transit time using the blue muffin and correlate breath hydrogen production with in vitro fermentation results.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited Kingdom

Timeline

N/ACompletedFinished
202420252026
First PostedJun 22, 2023
Enrollment StartMay 9, 2023
Primary CompletionAug 31, 2023
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 3.0 years ago

Interventions

Psylliumdietary

15g psyllium added to inulin solution to form a gel

Methylcellulosedietary

15 g methylcellulose added to inulin solution to form a gel

Maltodextrindietary

15g maltodextrin added to inulin solution to form a gel